Insights

Innovative Therapeutics Fresh Tracks Therapeutics focuses on developing groundbreaking treatments for autoimmune and inflammatory diseases, positioning it as a potential partner for companies seeking next-generation pharmaceutical solutions or collaborative research ventures in these specialized areas.

Recent Market Exit The company has announced the dissolution and termination of trading on the OTC Pink Market, indicating a strategic shift or restructuring, which may present opportunities for investors, licensing partners, or acquirers to engage during transitional phases.

Strategic Asset Divestment Following asset sales to Botanix Pharma Limited related to sofpironium bromide, Fresh Tracks has realigned its focus, potentially opening avenues to license or co-develop novel assets or compounds based on its core research and clinical outcomes.

Leadership & Scientific Focus With recent leadership changes and a newly formed Scientific Advisory Board emphasizing immunology and inflammation, the company offers opportunities for partnership in clinical research, talent acquisition, and collaborative development efforts in targeted therapeutic areas.

Funding & Revenue Profile Operating with a revenue range of 1 to 10 million dollars and limited financial backing, Fresh Tracks presents a valuable target for early-stage investment, strategic collaborations, or funding opportunities to accelerate its pipeline and commercial activities.

Fresh Tracks Therapeutics Tech Stack

Fresh Tracks Therapeutics uses 8 technology products and services including MySQL, Font Awesome, Swiper, and more. Explore Fresh Tracks Therapeutics's tech stack below.

  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Swiper
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • hCaptcha
    Security
  • Adobe Fonts
    Web Fonts
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Media & News

Fresh Tracks Therapeutics's Email Address Formats

Fresh Tracks Therapeutics uses at least 1 format(s):
Fresh Tracks Therapeutics Email FormatsExamplePercentage
FLast@frtx.comJDoe@frtx.com
50%
FLast@frtx.comJDoe@frtx.com
50%

Frequently Asked Questions

Where is Fresh Tracks Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics's main headquarters is located at 5777 Central Avenue Boulder, Suite 102. The company has employees across 1 continents, including North America.

What is Fresh Tracks Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics's official website is frtx.com and has social profiles on LinkedIn.

What is Fresh Tracks Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Fresh Tracks Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Fresh Tracks Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include President: R. H.Co-Founder: A. S.Chairman Of The Advisory Board: C. S.. Explore Fresh Tracks Therapeutics's employee directory with LeadIQ.

What industry does Fresh Tracks Therapeutics belong to?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Fresh Tracks Therapeutics use?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics's tech stack includes MySQLFont AwesomeSwiperjQueryhCaptchaAdobe FontsApache HTTP ServerApache.

What is Fresh Tracks Therapeutics's email format?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics's email format typically follows the pattern of FLast@frtx.com. Find more Fresh Tracks Therapeutics email formats with LeadIQ.

When was Fresh Tracks Therapeutics founded?

Minus sign iconPlus sign icon
Fresh Tracks Therapeutics was founded in 2009.

Fresh Tracks Therapeutics

Pharmaceutical ManufacturingColorado, United States11-50 Employees

When you create Fresh Tracks, you purposefully look to explore beyond. Beyond the obvious. Beyond the conventional. Beyond the imagination. 

Our company was built from and is guided by this belief. In turn, we strive to identify, pursue, and develop groundbreaking therapeutics to help millions of people struggling with devastating autoimmune, inflammatory, and other debilitating diseases.

Together, the executive management team and board of directors have a proven track record of leadership across early-stage research, product development, and global commercialization. They have served in leadership roles at large global pharmaceutical and biotech companies that successfully developed and/or launched first–in–class products, including Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta®, Juvederm®, Pluvicto®, and Sofpironium Bromide. 
 
We align this expert knowledge and clear vision to explore beyond the limitations of current therapies and accomplish something exceptional.

Section iconCompany Overview

Headquarters
5777 Central Avenue Boulder, Suite 102
Website
frtx.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Fresh Tracks Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Fresh Tracks Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.